Darzalex Faspro Gains US FDA AdComm Support For Smoldering Myeloma Claim

 
• By Bridget Silverman
  
J&J hopes to lead Darzalex Faspro to the first FDA-approved indication for smoldering multiple myeloma. (Shutterstock)

More from US Advisory Committees

More from Pathways & Standards